Proceedings of the PSK Conference (대한약학회:학술대회논문집)
- 2003.04a
- /
- Pages.156.2-157
- /
- 2003
Development of a Radiopharmaceutical using 166Ho-chitosan Complexes against Prostate Cancer
- Ryu, Jei-Man (Dong Wha Pharm. Ind. Co. Ltd.) ;
- Seong, Seung-Kyoo (Seoul National University College of Medicin) ;
- Bae, Eun-Jung (Institute of Whole Body Metabolis) ;
- Song, Young-Jun (Korea Atomic Energy Research Institut) ;
- Jung, Yong-Ho (Korea Atomic Energy Research Institut) ;
- Kwak, Chul (Korea Atomic Energy Research Institut) ;
- Park, Mun-Soo (Korea Atomic Energy Research Institut) ;
- Lee, Sang-Eun (Korea Atomic Energy Research Institut) ;
- Shigematsu, Akiyo (Korea Atomic Energy Research Institute)
- Published : 2003.04.01
Abstract
166Ho-chitosan complex (HC) is a new radiopharmaceutical approved in Korea for liver cancer. In these studies, therapeutic effect against prostate cancer and biodistribution of HC were evaluated in animal models using the technique of intraprostatic administration. For evaluation of the therapeutic effect, noble rats with AIT orthotopic or subcutaneous prostate cancer were used. (omitted)
Keywords